Katherine R. Calvo

Active 1997–2025

97
Papers
17,937
Citations
61
h-index
97
i10-index

Citations

Citations per year for Katherine R. Calvo1983: 3 citations1989: 1 citations1993: 1 citations1998: 5 citations1999: 8 citations2000: 9 citations2001: 13 citations2002: 11 citations2003: 10 citations2004: 11 citations2005: 17 citations2006: 22 citations2007: 16 citations2008: 14 citations2009: 9 citations2010: 4 citations2011: 24 citations2012: 39 citations2013: 67 citations2014: 80 citations2015: 122 citations2016: 113 citations2017: 140 citations2018: 135 citations2019: 551 citations2020: 647 citations2021: 806 citations2022: 702 citations2023: 653 citations2024: 1,103 citations2025: 471 citations2026: 16 citations1984–1988: no citations, so these years are not shown1990–1992: no citations, so these years are not shown1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,312 citing papers, 27.2% of this breakdownGermany: 586 citing papers, 6.9% of this breakdownItaly: 569 citing papers, 6.7% of this breakdownUnited Kingdom: 551 citing papers, 6.5% of this breakdownFrance: 521 citing papers, 6.1% of this breakdownChina: 473 citing papers, 5.6% of this breakdownSpain: 290 citing papers, 3.4% of this breakdownCanada: 275 citing papers, 3.2% of this breakdownAustralia: 239 citing papers, 2.8% of this breakdownNetherlands: 225 citing papers, 2.6% of this breakdownJapan: 192 citing papers, 2.3% of this breakdownSwitzerland: 184 citing papers, 2.2% of this breakdown
0%27.2%Other 24.5%

Fields

  • Medicine65.3%
  • Biochemistry, Genetics and Molecular Biology17.6%
  • Immunology and Microbiology15.3%
  • Neuroscience0.5%
  • Agricultural and Biological Sciences0.3%
  • Chemistry0.2%
  • Other0.8%

Topics

  • Acute Myeloid Leukemia Research7.6%
  • Immunodeficiency and Autoimmune Disorders3.7%
  • Chronic Lymphocytic Leukemia Research3.6%
  • CAR-T cell therapy research3.1%
  • Immune Cell Function and Interaction3.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.7%
  • Other76.2%

Coauthors

All papers

Open in search
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 cited by 2,693

  2. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natalie Deuitch, Dorota Rowczenio, Emily Rominger, Kristina V Wells, Chyi‐Chia Richard Lee, Weixin Wang, Megan Trick, James C. Mullikin, Gustaf Wigerblad, Stephen R. Brooks, Stefania Dell’Orso, Zuoming Deng, Jae Jin Chae, Alina Dulau‐Florea, May Christine V. Malicdan, Danica Novacic, Robert A. Colbert, Mariana J. Kaplan, Massimo Gadina, Sinisa Savic, Helen J. Lachmann, Mones Abu‐Asab, Benjamin D. Solomon, Kyle Retterer, William A. Gahl, Shawn M. Burgess, Ivona Aksentijevich, Neal S. Young, Katherine R. Calvo, Achim Werner, Daniel L. Kastner, Peter C. Grayson - New England Journal of Medicine 2020 cited by 1,154

  3. Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 472

  4. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

    Authors: , , , , , , , , , , , , , , , , , , , - Blood Advances 2021 cited by 234

  5. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edward W. Cowen, John J. DiGiovanna, Massimo Gadina, Andrew Lipton, Colleen Hadigan, Steven M. Holland, Joseph R. Fontana, Ahmad S. Alawad, Rebecca J. Brown, Kristina I. Rother, Theo Heller, Kristina M. Brooks, Parag Kumar, Stephen R. Brooks, Meryl Waldman, Harsharan K. Singh, Volker Nickeleit, Maria Silk, Apurva Prakash, Jonathan Janes, Seza Özen, Paul Wakim, Paul Brogan, William L. Macias, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2018 cited by 521

  6. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter C. Grayson, David B. Beck - Blood 2022 cited by 186

  7. The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer 2018 cited by 341

  8. Spectrum of clonal hematopoiesis in VEXAS syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colin O. Wu, Peter C. Grayson, Neal S. Young, David B. Beck, Bhavisha A. Patel, Mrinal M. Patnaik - Blood 2023 cited by 103

  9. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sinisa Savic, Daniel L. Kastner, Amanda K. Ombrello, David B. Beck, Peter C. Grayson - Arthritis & Rheumatology 2021 cited by 238

  10. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Ferguson, Polly J. Ferguson, Laura S. Finn, Marco Gattorno, Alexei A. Grom, Eric P. Hanson, Philip J. Hashkes, Christian M. Hedrich, Ronit Herzog, Gerd Horneff, Rita Jerath, Elizabeth A. Kessler, Hanna Kim, D. Kingsbury, Ronald M. Laxer, Pui Y. Lee, Min Ae Lee‐Kirsch, Laura B. Lewandowski, Suzanne C. Li, Vibke Lilleby, Vafa Mammadova, Lakshmi N. Moorthy, Gulnara Nasrullayeva, Kathleen M. O’Neil, Karen Onel, Seza Özen, Nancy Pan, Pascal Pillet, Daniela Gerent Petry Piotto, Marilynn Punaro, Andreas Reiff, Adam Reinhardt, Lisa G. Rider, Rafael Rivas‐Chacon, Tova Ronis, Angela Rösen‐Wolff, Johannes Roth, Natasha M. Ruth, Marite Rygg, Heinrike Schmeling, Grant S. Schulert, Christiaan Scott, Gisella Seminario, Andrew Shulman, Vidya Sivaraman, Mary Beth F. Son, Yuriy Stepanovskiy, Elizabeth Stringer, Sara Mansfield Taber, Maria Teresa Terreri, Cynthia J. Tifft, Troy R. Torgerson, Laura L. Tosi, Annet van Royen‐Kerkhof, Theresa Wampler Muskardin, Scott Canna, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2019 cited by 239

  11. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich - New England Journal of Medicine 2014 cited by 893

  12. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8

    Authors: , , , , , - Nature Methods 2006 cited by 431

  13. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 546

  14. An immune-based biomarker signature is associated with mortality in COVID-19 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andre Rastegar, Michael Stack, Katherine Myint‐Hpu, Susan L. Levinson, Mark J. DiNubile, Daniel S. Chertow, Peter D. Burbelo, Jeffrey I. Cohen, Katherine R. Calvo, John S. Tsang, Helen C. Su, John I. Gallin, Douglas B. Kuhns, Raphaela Goldbach‐Mansky, Michail S. Lionakis, Luigi D. Notarangelo - JCI Insight 2020 cited by 369

  15. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2013 cited by 706

  16. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

    Authors: , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2023 cited by 65

  17. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas A. Fleisher, Capucine Pïcard, Sylvain Latour, Sergio D. Rosenzweig - Journal of Clinical Investigation 2018 cited by 164

  18. Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2022 cited by 77

  19. Venous and arterial thrombosis in patients with VEXAS syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colin O. Wu, Yogendra Kanthi, Bhavisha A. Patel, Damon E. Houghton, Emma M. Groarke - Blood 2024 cited by 48

  20. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sergio D. Rosenzweig - New England Journal of Medicine 2016 cited by 245

  21. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome

    Authors: , , - Seminars in Hematology 2021 cited by 60

  22. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 cited by 636

  23. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2022 cited by 39

  24. A unified metric of human immune health

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Moir, Luigi Ferrucci, Karyl S. Barron, Ivona Aksentijevich, Steven H. Kleinstein, Danielle M. Townsley, Neal S. Young, Pamela A. Frischmeyer‐Guerrerio, Gülbu Uzel, Gineth Paola Pinto-Patarroyo, Cornelia Cudrici, Patrycja Hoffmann, Deborah L. Stone, Amanda K. Ombrello, Alexandra F. Freeman, Christa S. Zerbe, Daniel L. Kastner, Steven M. Holland, John S. Tsang - Nature Medicine 2024 cited by 46